Strong Q4 & FY Results

($ in millions, except EPS)

FY03 FY02 FY03 FY02

Revenues

Pharmaceutical Solutions $9,968 $8,763 +14% $38,406 $33,073 +16%

Medical-Surgical Solutions $ 684 $ 683 --- $ 2,743 $ 2,726 +1%

Information Solutions $ 314 $ 272 +15% $ 1,139 $ 1,004 +13%

Operating Profit

Pharmaceutical Solutions $ 301 $ 251 +20% $ 988 $ 802 +23% Medical-Surgical Solutions $ 17 $ 16 +3% $ 65 $ 64 +1%

Information Solutions $ 36 $ 3 NM $ 94 $ 22 +335%

Diluted Earnings per Share $ 0.62 $ 0.43 +44% $ 1.90 $ 1.44 +32%

from continuing operations

Operating Cash Flow $ 696 $ 326 +113%

Net Debt/Net Capital Ratio 14.0% 17.3%

4th Quarter

Note: Excluding sales to customers’ warehouses

Fiscal 2003